Cassava Sciences
2.33
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Cassava Sciences
Cassava Sciences, Inc., una compañía de biotecnología en etapa clínica, desarrolla medicamentos para enfermedades neurodegenerativas. Su principal candidato a producto terapéutico es simufilam, un fármaco de molécula pequeña, que ha completado el ensayo clínico de fase 2b; y el candidato a producto de diagnóstico en investigación es SavaDx, un biomarcador/diagnóstico basado en sangre para detectar la enfermedad de Alzheimer. La empresa se conocía anteriormente como Pain Therapeutics, Inc. y cambió su nombre a Cassava Sciences, Inc. en marzo de 2019. Cassava Sciences, Inc. se incorporó en 1998 y tiene su sede en Austin, Texas.
Trade GPT
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.